Krishna Life Sciences
Winner of India 5000 Best MSME Awards 2026
Krishna Life Sciences
Winner of India 5000 Best MSME Awards 2026
Details
Krishna Life Sciences
Sole Proprietorship
Pharmaceuticals
2014
20
Vadodara
Vadodara
Gujarat
390001
Introduction
Krishna Life Sciences was established on 16th January 2014 with a single product, Osteojod, a bone fracture healing accelerator. From its inception in Baroda, the company steadily expanded through adaptability, strong service orientation, quality-driven operations, technology-focused offerings, and concept-based brand building. With a consistent focus on customer satisfaction in the orthopedic segment, it achieved month-on-month and year-on-year growth while initially operating from a single headquarters.
Following the successful launch of its initial products, the company strategically expanded by adding new field force members, introducing additional products, and extending into new headquarters. Guided by careful planning and market-driven strategies, Krishna Life Sciences introduced new products every quarter based on performance evaluation and market acceptance. Today, the company offers more than 50 products in the orthopedic segment.
In 2024–25, the company launched a new division named Rohinee, dedicated exclusively to gynecology and IVF products. This division focuses on innovative and technology-oriented solutions, including several products introduced for the first time in India. Currently, the Rohinee division manages around 30 products in the gynecology segment, supported by a dedicated team operating across select headquarters in Gujarat.
Krishna Life Sciences believes in delivering quality products and services with a human touch. The company has been recognized with awards such as the Most Trusted Pharmaceutical Company in Vadodara, Business Excellence Awards, and Seva Bhushan Puraskar. It upholds the philosophy that quality is never accidental but the result of intelligent and dedicated efforts to serve humanity in an affordable and responsible manner.
